Wang, Haichen
Faw, Timothy D.
Lin, Yufeng
Huang, Shan
Venkatraman, Talaignair N.
Cantillana, Viviana
Lascola, Christopher D.
James, Michael L.
Laskowitz, Daniel T.
Funding for this research was provided by:
National Institutes of Health (NINDS 1 R41 NS108821-01)
Article History
Received: 2 October 2020
Accepted: 27 December 2020
First Online: 21 January 2021
Conflict of interest
: Dr. Laskowitz is an officer and has equity in Aegis CN, LLC which supplied the study drug. Dr. Wang serves as a consultant for and Dr. James has received grant funding from Aegis CN, LLC. Aegis CN, LLC had no editorial control over the study design, its execution, or the writing of this manuscript. Duke University has equity and an intellectual property stake in CN-105.
: All experiments were approved by and conducted in accordance with the Duke University Institutional Animal Care and Use Committee.